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Abstract
Background: Obesity has been associated with low-grade systemic inflammation, potentially leading to insulin resistance, type 2 diabe-
tes, dyslipidemia, and cardiovascular diseases. Even moderate weight loss through dietary changes and physical exercise is effective in 
preventing and managing obesity-associated disorders. The aim of this study was to determine the effect of weight loss in response to 
a lifestyle modification on the serum levels of inflammatory markers in obese children and adolescents.
Material and methods: Fifty obese subjects completed a six-month programme consisting of combined hypocaloric diet and moderate 
physical activity. High-sensitive C-reactive protein (CRP), interleukin-6 (IL-6), fibrinogen (FB), white blood count (WBC), glucose, insulin, 
insulin resistance index (HOMA IR), glycosylated haemoglobin (HbA1c), lipids as well as systolic (SBP) and diastolic blood pressure (DBP) 
were measured before and after intervention. 
Results: Patients had a 5.3 ± 3.4 kg average weight loss, with significant decreases of SDS-BMI, percentage of body fat, SDS-waist, SBP 
and DBP, HOMA-IR, HbA1c and reductions in serum IL-6, CRP, WBC, FB. In the multivariable linear models, changes in percentage of 
body fat and HOMA-IR were positively associated with favourable changes in inflammatory parameters.
Conclusion: This study demonstrates that weight reduction after successful lifestyle intervention results in improvements of blood inflam-
matory markers in obese children and adolescents. (Pol J Endocrinol 2011; 62 (6): 499–505)
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Streszczenie
Wstęp: Otyłość wiąże się z obecnością niewielkiego stopnia stanu zapalnego, potencjalnie prowadzącego do insulinooporności, cukrzycy 
typu 2, dyslipidemii i chorób sercowo-naczyniowych. Nawet umiarkowane obniżenie masy ciała dzięki zmianie diety i zwiększonej 
aktywności fizycznej zapobiega występowaniu zaburzeń związanych z otyłością. Celem pracy była ocena wpływu obniżenia masy ciała 
(w wyniku modyfikacji stylu życia) na stężenie wskaźników stanu zapalnego w surowicy otyłych dzieci i młodzieży.
Materiał i metody: W 6-miesięcznym programie polegającym na stosowaniu ubogokalorycznej diety i umiarkowanej aktywności fizycznej 
uczestniczyło 50 otyłych pacjentów. W warunkach podstawowych i po 6 miesiącach oznaczano: białko C-reaktywne (CRP), interleukinę 6 
(IL-6), fibrynogen (FB), leukocyty (WBC), glukozę, insulinę, wskaźnik insulinooporności (HOMA-IR), hemoglobinę glikozylową (HbA1c), 
lipidy, ciśnienie tętnicze krwi skurczowe (SBD) i rozkurczowe (DBD).
Wyniki: Średni spadek masy ciała u pacjentów wynosił 5,3 ± 3,4 kg, ze znaczącą redukcją wartości SDS-BMI, procentowej zawartości 
tłuszczu, SDS-obwodu pasa, SBP i DBP, HOMA-IR, HbA1c oraz obniżeniem stężeń IL-6, CRP, WBC, FB w surowicy. W wieloczynnikowej 
analizie regresji zmiany w procentowej zawartości tłuszczu i HOMA-IR były pozytywnie skorelowane z podobnymi zmianami wskaźników 
stanu zapalnego.
Wnioski: Redukcja masy ciała w efekcie zmiany stylu życia wpływa na poprawę wskaźników stanu zapalnego u otyłych dzieci i młodzieży.
(Endokrynol Pol 2011; 62 (6): 499–505)
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Introduction
Obesity is known to be an important risk factor for the 
development of insulin resistance potentially lead-
ing to several life-threatening disorders such as type 
2 diabetes mellitus, atherosclerosis and hypertension 
[1]. A common cause of these co-morbidities of obesity 
may be the chronic, low-grade systemic inflammation, 
characterised by increased serum levels of inflammatory 
cytokines such as interleukin-6 (IL-6), interleukin-1b, 
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tumour necrosis factor-a, and many other blood mark-
ers suggesting systemic inflammation such as C-reactive 
protein (CRP), white blood count (WBC) and fibrinogen 
(FB) [2, 3]. 
Main sources of inflammatory cytokines are 
adipocytes per se as well as the immune cells local-
ised within expanded adipose tissue [4, 5]. It is now 
recognised that the expansion of fat tissue associated 
with obesity results in more blood vessels, more con-
nective tissue fibroblasts, and especially more macro-
phages. Apart from adipocytes, other cells located in 
adipose tissue such as endothelial cells, fibroblasts, and 
immune cells, may secrete inflammatory cytokines and 
chemokines. In particular, visceral adipose tissue is 
known to release a larger amount of interleukins and 
inflammatory cytokines than abdominal subcutaneous 
adipose tissue [4]. 
The principal inflammatory molecule is C-reactive 
protein, which is primarily synthesised and secreted by 
the liver in response to adipocyte-derived interleukin-6, 
and both molecules are strongly associated with obesity 
and cardiovascular disease [6]. 
Numerous studies in obese adults and children 
have shown that even moderate weight loss through 
dietary changes and physical exercise is effective in 
preventing and managing obesity-associated disorders 
[7]. The achieved weight loss is associated with dimin-
ished cardiovascular risk and an improved quality of 
life [8]. Since a hypocaloric diet and physical train-
ing have been shown to improve body composition 
through reduction of body fat stores, it is hypothesised 
that an intervention utilising dietary changes and 
increased physical activity may also improve markers 
of inflammation. 
There have been only a few studies concerning the 
effect of weight loss on circulating levels of inflamma-
tory biomarkers, with contradictory results. Some of 
these studies have shown a reduction of proinflamma-
tory cytokine IL-6 [9] and retinol binding protein-4 [10] 
in response to weight reduction. With regard to CRP, 
Heilbronn et al. [11] found that its elevated concentra-
tion in obese individuals decreased in parallel with de-
creasing body weight, whereas Bastard et al. [9] showed 
no change in response to weight loss. 
As a result of these controversial findings, and the 
small amount of longitudinal data, we studied the 
changes in selected blood inflammatory markers after 
weight reduction in obese children and adolescents. 
Material and methods
We examined anthropometric parameters, fasting 
glucose, insulin and blood inflammatory markers in 
50 obese children and adolescents (boys and girls), 
aged 8 to 18 years, attending the Outpatients Clinic 
for Children with Metabolic Disorders. Obesity was 
recognised on the basis of body mass index (BMI) above 
the 97th percentile for age and sex on BMI percentile 
charts. Reference data for Polish children were used 
[12]. Children with acute or chronic infections, as well 
as children with significant medical conditions such as 
genetic syndromes, cancers, autoimmunologic diseases, 
hepatic or renal dysfunction, and endocrine disorders 
were excluded. All patients were non-smokers without 
any regular medication.
The protocol of the study was approved by the Ethi-
cal Committee of the Pomeranian Medical University. 
All patients participated in the six-month obesity 
intervention programme. Our outpatient interven-
tion programme for obese children was based on 
increased physical activity, nutrition education, and 
behaviour therapy including individual psychologi-
cal care of the child, and, if necessary, the child’s 
family. The exercise therapy included instructions 
in physical exercise as part of everyday life and in 
reducing the amount of time spent watching televi-
sion or playing computer games. The nutritional 
intervention consisted of a targeted reduction in fat 
and sugar intake. 
Anthropometric measurements (body height and 
weight, waist circumference) were performed by 
trained personnel. Height was measured to the nearest 
centimetre using a rigid stadiometer. Weight was meas-
ured in underwear to the nearest 0.1 kg using an elec-
tronic scale. Body mass index (BMI) was calculated by 
dividing weight in kilograms by height in square metres 
(kg/m2). Since BMI changes with age, standard deviation 
score (SDS)-BMI was also calculated [12]. A substantial 
weight loss over the course of six months was defined 
as a reduction of SDS-BMI greater than 0.5. 
 Percentage body fat (% FAT) and fat mass (in kg) 
were measured using the bioimpedance method (Bio-
electrical Impedance Analyzer Tanita 131, Japan) with 
an applied current of 0.8 mA at a fixed frequency of 50 
kHz. Waist circumference was measured as the minimal 
abdominal circumference between the xiphoid process 
and iliac crest. Because waist circumference changes 
with age, waist-SDS was also calculated, separately for 
boys and girls [13]. Pubertal development stage was 
assessed using the standards of Marshall and Tanner. In 
girls, breast stage was used if there was a discrepancy 
between breast and pubic hair development. In boys, 
pubic hair was used if there was a discrepancy between 
genitalia and pubic hair staging. 
Systolic and diastolic blood pressure (SBP and 
DBP) were measured according to guidelines at the 
right arm after a 10-minute rest by using a calibrated 
sphygmomanometer. 
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Blood samples were obtained in the fasting state at 
8a.m. and centrifuged immediately. Serum specimens 
for IL-6 were frozen at –80oC and thawed only once 
for analysis, whereas all blood glucose, insulin, CRP, 
fibrinogen, HbA1c, lipids and WBC determinations 
were performed immediately. Circulating IL-6 levels 
were determined by the ELISA method using the 
Quantikine kit (R&D System, Minneapolis, MN, USA). 
The minimum detectable concentration was 0.10 pg/mL, 
and the interassay coefficient of variation was 7.0% 
for this kit. CRP was measured by the high-sensitivity 
immunoturbidimetric method (CRP-Latex, Olympus) 
and FB — in citrated plasma with a modified clot-rate 
assay using the Diagnostica STAGO ST4 instrument. 
Serum glucose levels were measured with the glucose 
oxidase technique (Glucose HK Analyzer, Olympus). 
Free insulin concentration was determined by RIA 
(Pharmacia RIA kit). HbA1c was measured by the im-
munoturbidimetric method. Total cholesterol (T-chol), 
HDL cholesterol (HDL-chol) and triacylglycerol (TG) 
levels were measured in serum by automated enzymatic 
procedures (Olympus). LDL cholesterol (LDL-chol) was 
determined after separating LDL fraction from fresh 
sera by sequential ultracentrifugation, using an Olym-
pus commercial kit. 
Fasting glucose and insulin concentrations were 
used to calculate the homeostasis model assessment 
for insulin resistance (HOMA-IR). The formula for 
HOMA-IR is as follows: 
HOMA-IR = fasting blood glucose [mmol/L] × fasting 
insulin [mIU/mL]/22.5 [14]
Statistical analyses were performed using the STATA 
11 software package. Data was presented as mean and 
standard deviation (± SD), and changes were shown 
as mean difference change from baseline (D) ± SD. 
Changes were expressed as D variable and calculated as 
variable measured at baseline minus variable measured 
six months later. Non-normally distributed variables 
were log-transformed before statistical analysis. 
For analysis (the baseline study vs. the follow-up 
assessment at six months), a paired Student t test was 
used for parametric data and Wilcoxon sign rank test 
for nonparametric data. Inflammatory markers’ levels 
were correlated to other variables by Pearson’s correla-
tion, whereas Spearman’s correlation was used to assess 
the relationships between changes in inflammatory 
markers and changes in other continuous measurement 
improvements. Multiple linear regression analyses with 
inflammatory markers as dependent variables were 
performed with the independent variables such as age, 
sex, pubertal stage, SDS-BMI and others that had shown 
a significant correlation to the dependent variable in 
univariate analysis. Sex and pubertal stage were used as 
categorical markers in all these models. P value < 0.05 
was considered as significant.
Results
There were significant differences between all studied 
parameters, both clinical and biochemical, at baseline 
and following the intervention (Table I). After six 
months, a significant reduction of glucose and insulin 
concentration, HOMA-IR, HbA1c as well as SBP and DBP 
were observed. Furthermore, concentrations of IL-6, 
CRP, WBC and FB decreased significantly. 
Pearson’s correlation coefficients of patients’ char-
acteristics and inflammatory biomarkers at baseline are 
presented in Figure 1.
At baseline, univariate Pearson’s correlation analysis 
showed a significant positive correlation between de-
gree of overweight (as SDS-BMI) and IL-6 (p < 0.000), 
CRP (p = 0.001), WBC (p < .000) and FB (p = 0.004), per-
centage of body fat and IL-6 (p = 0.003), CRP (p = 0.02), 
WBC (p < 0.000) and FB (p = 0.01), SDS-waist and IL-6 
(p < 0.000), CRP (p = 0.002), WBC (p < 0.000) and FB 
(p < 0.000). Strong positive associations were also found 
between IL-6 and other blood inflammatory markers 
and HOMA-IR, insulin, (but not glucose), systolic and 
diastolic blood pressure (Figure 1). 
Correlation of the magnitude of changes (D) be-
tween different parameters are presented in Table II. 
Regarding all 50 patients who participated in the life-
style intervention programme, changes of SDS-BMI and 
percentage body fat correlated positively with changes 
in IL-6 and CRP. Changes of IL-6 correlated significantly 
with HOMA-IR, CRP, and FB. There were strong cor-
relations between changes of different inflammatory 
markers.
Clinical and biochemical parameters of subjects were 
used in multivariable models with changes of blood in-
flammatory markers’ concentrations (D) as a dependent 
variable. Results are presented in Table III. 
Changes in blood inflammatory markers after six 
months of lifestyle intervention, with the exception of fi-
brinogen, were independently correlated with changes 
in HOMA-IR and changes in adiposity. 
Discussion 
In this study, we examined blood inflammatory mark-
ers and their correlation to weight status and insulin 
resistance in obese children and adolescents before 
and after successful lifestyle intervention. Significant 
correlations were found between the degree of adipos-
ity (as SDS-BMI and percentage of body fat) and blood 
inflammatory markers. Moreover, in our study, serum 
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levels of inflammatory parameters positively correlated 
with insulin resistance, expressed as fasting insulin and 
insulin resistance index (HOMA-IR). Therefore, our data 
suggests that proinflammatory cytokine IL-6 and other 
blood markers of systemic inflammation are associated 
with insulin resistance and that these correlations can 
mainly be attributed to obesity [3]. A previous study 
also clearly demonstrated that obesity in children is 
associated with higher C-reactive protein concentra-
tions and higher white blood cell counts compared to 
normal weight children [2]. In our study, a control group 
(subjects with normal body mass) was not included, 
because the main goal of this study was to determine 
the changes in inflammatory parameters associated with 
weight loss in obese children. 
Six months of lifestyle modification through com-
bined diet and physical exercise significantly reduced 
body weight and adiposity, waist circumference, blood 
pressure, fasting glucose, insulin, and HbA1c, and im-
proved insulin resistance and lipids’ profile. Successful 
intervention was also associated with a significant re-
duction in serum IL-6, CRP, WBC, and fibrinogen levels. 
It has been shown that IL-6 concentrations increase 
with adiposity, and that ~ 30% of circulating IL-6 may 
Table I. Physical and biochemical characteristics at baseline and following six months of obesity intervention programme
Tabela I. Charakterystyka badanej grupy w warunkach podstawowych i po 6 miesiącach modyfikacji stylu życia
Parameter Baseline 6 months later D p value
Age (years) 14.2 ± 2.6 14.8 ± 2.6 (+) 0.6 ± 0.2 0.000
Male/female, n (%) 21 (42)/29 (58) 21/29 – –
Pubertal stage
1 n (%) 4 (8) 3 (6) – –
2 n (%) 8 (16) 5 (10)
3 n (%) 5 (10) 4 (8)
4 n (%) 4 (8) 6 (12)
5 n (%) 29 (58) 32 (64)
Body mass [kg] 83.6 ± 17.5 78.25 ± 16.9 (–) 5.3 ± 3.4 0.000
BMI 30.8 ± 3.9 28.1 ± 4.2 (–) 2.7 ± 1.5 0.000
SDS-BMI 3.9 ± 1.4 2.9 ± 1.6 (–) 1.0 ± 0.6 0.000
% FAT 35.6 ± 6.9 30.9 ± 9.1 (–) 4.7 ± 4.5 0.000
Fat mass [kg] 29.9 ± 10.2 24.6 ± 10.5 (–) 5.3 ± 4.3 0.000
Waist [cm] 102.1 ± 11.5 96.7 ± 11.6 (–) 5.4 ± 4.1 0.000
SDS-waist 4.4 ± 1.4 3.5 ± 1.5 (–) 0.8 ± 0.5 0.000
SBP [mm Hg] 126.9 ± 10.7 115.2 ± 8.2 (–) 11.7 ± 7.6 0.000
DBP [mm Hg] 79.7 ± 9.3 69.2 ± 8.8 (–) 10.5 ± 6.5 0.000
IL-6 [pg/mL] 2.1 ± 0.8 1.0 ± 0.6 (–) 1.1 ± 0.6 0.000
CRP [ng/mL] 1.5 ± 0.8 0.7 ± 0.5 (–) 0.8 ± 0.5 0.000
WBC [G/L] 7.3 ± 1.4 5.9 ± 1.1 (–) 1.4 ± 0.8 0.000
FB [mg/dL] 329.2 ± 55.7 278.1 ± 40.0 (–) 51.1 ± 41.5 0.000
Glucose [mmol/L] 5.1 ± 0.5 4.9 ± 0.4 (–) 0.3 ± 0.01 0.001
Insulin [μU/mL] 21.5 ± 9.3 14.0 ± 5.6 (–) 7.5 ± 5.7 0.000
HOMA-IR 4.9 ± 2.4 3.0 ± 1.4 (–) 1.9 ± 1.5 0.000
HbA1c [%] 5.7 ± 0.3 5.3 ± 0.3 (–) 0.4 ± 0.25 0.000
T-chol [mg/dL] 166.2 ± 27.0 155.4 ± 21.9 (–) 10.9 ± 8.4 0.002
HDL-chol [mg/dL] 43.5 ± 11.7 50.5 ± 11.8 [+) 7.0 ± 5.4 0.000
LDL-chol [mg/dL] 100.4 ± 24.6 85.3 ± 20.6 (–) 15.0 ± 12.7 0.000
TG [mg/dL] 128.5 ± 49.9 93.2 ± 41.0 (–) 35.3 ± 28.9 0.000
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Table II. Pearson’s correlation coefficient of weight status, HOMA-IR, and inflammatory parameters before and after 
six-month lifestyle intervention
Tabela II. Ocena zależności między wielkością zmian parametrów antropometrycznych, HOMA-IR i wskaźników stanu 
zapalnego w efekcie modyfikacji stylu życia w korelacji Pearsona
FB  D SDS-BMI  D % fat  D SDS-waist  D HOMA-IR  D IL-6  D CRP  D WBC  D FB
D SDS-BMI  r  –    0.33  0.22  0.15  0.03
 P      .020  .128  .290  .862
D % fat  r   –   0.48  0.33  0.13  0.03
 P      .000  .019  .369  .835
D SDS-waist  r    –  0.39  0.18  0.08  0.11
 P      .007  .230  .605  .465
D HOMA-IR  r    – 0.64 0.29 0.37 0.14
 P     .000 .049 .007 .336
D IL-6 r 0.33 0.48 0.39 0.64 – 0.32 0.09 0.30
 P .020 .000 .007 .000  .022 .521 .043
D CRP r 0.22 0.33 0.18 0.28 0.32 – 0.18 0.09
 P .128 .019 .230 .052 .022  .209 .568
D WBC r 0.15 0.13 0.08 0.37 0.09 0.18 – 0.09
 P .290 .369 .605 .007 .521 .209  .532
D FB r 0.03 0.03 0.11 0.14 0.30 0.09 0.09 –
 P .862 .835 .465 .336 .043 .568 .532
Figure 1. Pearson’s correlation coefficients of patients’ characteristics and inflammatory parameters at baseline. r — correlation 
coefficients; A — age; PS — pubertal stage; BMI — body mass index; SDB-SDS BMI; F% — percentage body fat; FM — fat mass; 
W — waist; SDW — SDS waist; GL — glucose; INS — insulin; HIR — HOMA-IR; CH — total cholesterol; HDL — HDL cholesterol; 
LDL — LDL cholesterol; TG — triacylglycerol; FB — fibrinogen; IL6 — cytokine IL-6; HBA — HbA1c; CRP — C-reactive proteins; 
SBP — systolic blood pressure; DBP — diastolic blood pressure; WBC — white blood count
Rycina 1. Ocena zależności między badanymi parametrami a wskaźnikami stanu zapalnego w warunkach podstawowych w korelacji 
Pearsona
be released by subcutaneous fat tissue [15]. Our results 
showed that serum IL-6 concentrations decreased 
significantly after weight loss in obese children. IL-6 
seems to play an important role in weight-regulating 
processes: it inhibits lipoprotein lipase, down-regulates 
fat tissue triacylglycerol deposition, stimulates thermo-
genesis and satiety through the synthesis of prostag-
landins and corticotrophin-releasing factor, therefore 
contributing to body weight homeostasis [16]. The 
decrease in IL-6 concentration indicates that, in the 
absence of acute infection, changes in body fat mass 
may influence serum IL-6 levels. However, previous 
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investigations examining the ability of weight loss to 
alter serum IL-6 concentrations have provided mixed 
results. Monzillo et al. [17] found that weight reduction 
in obese subjects with insulin resistance was associated 
with a significant decrease in circulating IL-6. On the 
other hand, Roth et al. [18] did not find a reduction of 
IL-6 in the successful weight reduction group of obese 
children, confirming results from Olson et al. [19], who 
did not find changes of IL-6 and CRP after weight 
loss in overweight women participating in a one-year 
dietary and fitness programme. These disparities may 
be related to acute and chronic phases of the inflam-
matory response to exercise training. The decrease in 
IL-6 and CRP levels due to reduction of overweight 
was counterbalanced by increased muscular injury and 
inflammation caused by increased physical activity 
[20], which is an integral part of all weight reduction 
programmes. 
C-reactive protein, a marker of inflammation and 
a powerful predictor of cardiovascular risk, has been 
previously shown to be elevated in obese patients, 
suggesting a state of chronic, low-grade systemic 
inflammation [21]. The current study showed that 
serum CRP concentrations decreased significantly 
after the intervention, although this finding was less 
evident than the reduction in IL-6. Heilbronn at al. 
[11] found that elevated CRP levels in obese women 
were reduced by 26%, but not normalised, after a very 
low-fat, energy restricted diet for 12 weeks. Previous 
studies have shown that serum CRP concentration 
is regulated by IL-6 derived from adipose tissue. We 
found positive correlations between serum CRP and 
IL-6 at baseline and after intervention, confirming 
that CRP is, at least in part, regulated by IL-6 from 
fat tissue store. 
This study was the first to analyse prospectively 
WBC after a weight loss programme. WBC significantly 
decreased in response to the lifestyle intervention. 
Whether WBC is altered in response to weight reduc-
tion and/or plays a role in insulin resistance remains 
to be seen. 
Conclusion 
Our data showed that weight reduction in obese chil-
dren, in addition to improving insulin sensitivity and 
lipids’ profile, also leads to a significant reduction in 
blood inflammatory markers. 
Further studies are necessary to investigate wheth-
er the association between weight loss and changes of 
several proinflammatory adipocytokines is causally 
associated with improvement of insulin resistance, 
and may be useful in the prevention of obesity-related 
disorders. 
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